New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 30, 2014
12:27 EDTHUM, GNW, RT, REGN, TWTR, DEST, NQOn The Fly: Midday Wrap
Stocks on Wall Street were mixed at midday, with the Nasdaq leading and the Dow lagging, after a much better than expected reading on second quarter economic growth in the U.S. and ahead of a statement from the Federal Reserve following its latest policy meeting. With a solid earnings season and the economic data showing growth, investors are now on Fed watch, with the move in the averages potentially illustrating fear that the central bank may begin to get more hawkish. ECONOMIC EVENTS: In the U.S., the Commerce Department estimated that Gross Domestic Product grew at a seasonally adjusted annual rate of 4.0% in the second quarter, easily beating expectations for a growth rate of 3.0%. Payroll company ADP reported private payrolls climbed 218K in July, which was a bit below the 238K forecast. The Federal Reserve wraps up its two-day Federal Open Market Committee meeting today and the accompanying rate decision and statement is scheduled to be released at 2:00 pm ET. COMPANY NEWS: Shares of Twitter (TWTR) surged 20% higher after the social network operator's second quarter results beat analysts' consensus estimates and it raised its fiscal year 2014 revenue and adjusted EBITDA forecasts. Following last night's report, Bank of America Merrill Lynch upgraded Twitter to Buy from Neutral, while the stock was also upgraded to Outperform from Sector Perform at FBN Securities, to Neutral from Sell at UBS and to Market Perform from Underperform at Cowen. MAJOR MOVERS: Among the notable gainers was NQ Mobile (NQ), which jumped 15% to trade near $8 per share after the company reported it has received a non-binding proposal from Bison Capital to acquire all of NQ's outstanding American depositary shares for $9.80 each. Also higher was Regeneron (REGN), which rose 6% after the company announced that nine new Phase 3 Odyssey trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint. Among the noteworthy losers was Genworth Financial (GNW), which dropped 13% and was downgraded to Neutral from Outperform at Macquarie after its second quarter earnings report. Also lower following their earnings reports were Humana (HUM), which slid 5%, Ruby Tuesday (RT), which fell over 16%, and Destination Maternity (DEST), which dropped more than 19%. INDEXES: Near midday, the Dow was down 57.70, or 0.34%, to 16,854.41, the Nasdaq was up 9.01, or 0.2%, to 4,451.71, and the S&P 500 was down 3.87, or 0.2%, to 1,966.08.
News For TWTR;GNW;NQ;REGN;HUM;DEST;RT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
February 19, 2015
09:01 EDTREGNData to accelerate growth of Regeneron's Eylea, says Bernstein
Subscribe for More Information
07:28 EDTREGNRegeneron data better than expected, says RBC Capital
RBC Capital believes that Protocol-T results for Regneron's (REGN) Eylea were better than expected. The firm says that Eylea improved the vision of all patients more than Roche's treatments,and was much better than Roche's drugs in treating patients with moderate or worse vision loss. The firm keeps a $490 price target and Outperform rating on Regeneron.
06:56 EDTREGNData support Regeneron drug over competition, says Deutsche Bank
Subscribe for More Information
06:45 EDTREGNStudy shows Roche's treatments equal to Eylea in most cases, NY Times says
Subscribe for More Information
February 18, 2015
17:23 EDTREGNRegeneron reports positive results for Eylea injection in diabetic macular edema
Subscribe for More Information
16:00 EDTTWTROptions Update; February 18, 2015
Subscribe for More Information
10:32 EDTGNWOptions with decreasing implied volatility
Subscribe for More Information
09:37 EDTTWTROption volume leaders on open
Option volume leaders: AAPL TSLA TWTR CELG APO NFLX AXP APA LNKD C GILD according to Track Data.
08:32 EDTTWTRUC Berkeley Haas School of Business to hold a discussion
Gabriel Stricker, Chief Communications Officer of Twitter, holds a discussion, "Twitter and Free Speech" in Berkeley, California on February 18 at 3:30 pm. Webcast Link
07:13 EDTTWTRNational Association of Regulatory Utility Commission to hold a meeting
Subscribe for More Information
06:56 EDTHUMObamacare enrollment exceeded goal, Politico reports
Subscribe for More Information
03:20 EDTREGNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
February 17, 2015
16:00 EDTTWTROptions Update; February 17, 2015
Subscribe for More Information
11:14 EDTNQBlock sees 'pure speculation' as only reason investors hold NQ Mobile stock
Subscribe for More Information
10:51 EDTGNWOptions with decreasing implied volatility
Subscribe for More Information
10:01 EDTREGNCVS says PCSK9 inhibitors could cost system $150B annually
Subscribe for More Information
10:00 EDTREGNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Box, Inc. (BOX) initiated with a Hold at Canaccord... Euronav NV (EURN) initiated with an Overweight at Morgan Stanley... GoPro (GPRO) initiated with an Outperform at Northland... M/A-COM (MTSI) initiated with a Neutral at BofA/Merrill... Macy's (M) initiated with an Underweight at Barclays... NetSuite (N) initiated with an Underperform at Exane BNP Paribas... Omega Healthcare (OHI) initiated with a Neutral at BofA/Merrill... Pandora (P) initiated with a Neutral at Macquarie... Pattern Energy (PEGI) coverage resumed with an Outperform at BMO Capital... Regeneron (REGN) initiated with an Outperform at Bernstein... Trovagene (TROV) initiated with an Overweight at Piper Jaffray... Vista Outdoor (VSTO) initiated with a Market Perform at Cowen.
09:40 EDTTWTRActive equity options trading on open
Subscribe for More Information
09:19 EDTTWTRTwitter still the large cap Internet stock to own this year, says MKM Partners
Subscribe for More Information
06:35 EDTREGNRegeneron initiated with an Outperform at Bernstein
Target $475.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use